CLDF Title
Contact Us | Bookmark
Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights

Featured Programs
  Liver News - REUTERS   Congress Calendar   Physician Resources  
Roche buys U.S. biotech Jecure in race for liver disease drugs
REFILE-Alcohol consumption cutoffs do not identify gastric bypass patients with alcohol problems
Alcohol consumption cutoffs do not identify gastric bypass patients with alcohol problems
In half of hepatitis C patients, DAA treatment can shortened to 6 weeks
Screening, brief behavioral counseling can reduce unhealthy alcohol use
View Complete News Library
View all Congresses
  Featured Abstracts          
Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis?
Management of Recurrent and De Novo NAFLD/NASH after Liver Transplantation
Validation of Serum Test for Advanced Liver Fibrosis in Patients with Nonalcoholic Steatohepatitis
BET Inhibition Improves NASH and Liver Fibrosis
Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
What is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States
Management of chronic hepatitis B during pregnancy
Serum HBV RNA: a New Potential Biomarker for Chronic Hepatitis B Virus Infection
Combination of entecavir/ peginterferon alfa-2a in children with HBeAg-positive immune tolerant chronic hepatitis B virus infection
Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues
The actual management of Hepatitis B and Hepatitis C in children
Glecaprevir/Pibrentasvir in Patients with Chronic HCV Genotype 3 Infection: An Integrated Phase 2/3 Analysis
National Trends in Liver Transplantation in Older Adults
Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus (HCV) Management in Opioid Use Disorder Patients on Methadone
Improved Liver Transplant Waitlist Mortality and Lower Risk of Disease Progression Among Chronic Hepatitis C Patients Awaiting Liver Transplantation After the Introduction of Direct Acting Antiviral Therapies in the United States
Sex hormone levels by presence and severity of cirrhosis in women with chronic hepatitis Cvirus infection
The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic disease
Hepatitis C Virus in Women of Childbearing Age, Pregnant Women, and Children
Care of Incarcerated Patients
Telementoring for hepatitis C treatment in correctional facilities
Future Trends in Demand for Liver Transplant: Birth-Cohort Effects among Patients with NASH and HCC
Gut microbiota, fatty liver disease, and hepatocellular carcinoma
Systemic therapy for hepatocellular carcinoma: beyond sorafenib
Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
Hyperammonemia in Hepatic Encephalopathy
Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Effects of branched chain amino acid supplementation on patient care outcomes in adults and children with liver cirrhosis: A systematic review
Frailty, Psychoactive Medications, and Cognitive Dysfunction are Associated with Poor Patient-Reported Outcomes in Cirrhosis
Hepatic encephalopathy: Sometimes more portal than hepatic
Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)
Valproic acid induced acute liver injury resulting in hepatic encephalopathy- a case report and literature review
A Novel Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of NAFLD and HCC
Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
Non-alcoholic fatty liver disease: a narrative review of genetics
Hepatitis B virus infection is not associated with fatty liver disease: Evidence from a cohort study and functional analysis
Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis
Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease
          View All Abstracts  
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
CLDF Sponsors & Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
CLDF Follow Us
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2019 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.